FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Amarin news from FierceBiotech

News

ALSO NOTED: Ambrilia touts data; Amarin raises $60M; and much more...

> Ambrilia Biopharma reported positive 24-week Phase III top-line results for prolonged-release formulation of Octreotide. Read more...

ALSO NOTED: Phyton cuts staff; Alzheimer's: A new indication for Enbrel?; and much more...

> According to research released today, the anti-rheumatoid arthritis med Enbrel has shown an amazing ability to rehabilitate Alzheimer's patients. Read more...

Press Releases

PRESS RELEASE: Amarin Corporation to Buy Privately Held Ester Neurosciences for up to $17M

Amarin Corporation to Buy Privately Held Ester Neurosciences for up to $17M LONDON, December 5 -- Amarin Corporation today announced that the Company has: - Signed an agreement to acquire Ester Read more...